Related Experiment Video

Updated: May 22, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Antigen-specific immunotherapy in ovarian cancer and p53 as tumor antigen

Renee Vermeij1, Ninke Leffers, Cornelis J Melief

  • 1University Medical Center Groningen, Department of Gynecologic Oncology, 9700 RB Groningen, The Netherlands.

Current Pharmaceutical Design
|May 18, 2012
PubMed

Insights

Immunotherapy shows promise for ovarian cancer, with p53 vaccines inducing immune responses. However, significant tumor reduction requires combining immunotherapy with surgery, chemotherapy, or targeted therapies.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Immunotherapy is an emerging treatment for epithelial ovarian cancer.
  • Approximately 50% of ovarian cancers harbor p53 mutations, making it a potential target for immunotherapy.

Purpose of the Study:

  • To review the efficacy of p53-targeting vaccines in ovarian cancer patients.
  • To identify challenges in current immunotherapy study designs and propose solutions.

Main Methods:

  • Review of existing studies on ovarian cancer immunotherapy, focusing on p53 vaccines.
  • Analysis of immunological and clinical responses in vaccinated patients.

Main Results:

  • Antigen-specific immune responses were observed in most studies following vaccination.
  • No significant reduction in tumor burden was reported in clinical responses.

Conclusions:

  • While p53 vaccines can elicit immune responses, they have not yet led to significant clinical benefits in ovarian cancer.
  • Multimodality treatment, integrating immunotherapy with surgery, chemotherapy, and targeted therapy, is crucial for improving outcomes.

More Related Videos

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...